투자판단관련주요경영사항(자회사의 주요경영사항) (항암 신약 후보물질 Licensein 계약 체결)[유]
Received: 4/1/2026 · Reporter: LG
A summary for this filing type is not yet available. Please refer to the original DART filing.
🏢 Past 12 months filing pattern (this company)
- Total filings
- 53 filings
- Same category
- 44 filings
- Previous same-category filing
- 5/7/2026
- Corrections / withdrawals
- 2 filings
Filing source / License
The original PDF/HTML of this filing is provided by FSS DART. MarketBubbles displays only metadata (title, receipt number, type, reporter) and a rule-based summary; we do not mirror the original PDF body (per FSS ToS).